238 related articles for article (PubMed ID: 19959474)
1. Heparin enhances serpin inhibition of the cysteine protease cathepsin L.
Higgins WJ; Fox DM; Kowalski PS; Nielsen JE; Worrall DM
J Biol Chem; 2010 Feb; 285(6):3722-3729. PubMed ID: 19959474
[TBL] [Abstract][Full Text] [Related]
2. Cross-class inhibition of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1: a kinetic analysis.
Schick C; Pemberton PA; Shi GP; Kamachi Y; Cataltepe S; Bartuski AJ; Gornstein ER; Brömme D; Chapman HA; Silverman GA
Biochemistry; 1998 Apr; 37(15):5258-66. PubMed ID: 9548757
[TBL] [Abstract][Full Text] [Related]
3. Human SCCA serpins inhibit staphylococcal cysteine proteases by forming classic "serpin-like" covalent complexes.
Kantyka T; Potempa J
Methods Enzymol; 2011; 499():331-45. PubMed ID: 21683261
[TBL] [Abstract][Full Text] [Related]
4. Heparan sulfate/heparin glycosaminoglycan binding alters inhibitory profile and enhances anticoagulant function of conserved Amblyomma americanum tick saliva serpin 19.
Radulović ŽM; Mulenga A
Insect Biochem Mol Biol; 2017 Jan; 80():1-10. PubMed ID: 27845251
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Plasmodium falciparum cysteine protease falcipain-2 by a human cross-class inhibitor serpinB3: A mechanistic insight.
Alam B; Biswas S
Biochim Biophys Acta Proteins Proteom; 2019 Sep; 1867(9):854-865. PubMed ID: 31247344
[TBL] [Abstract][Full Text] [Related]
6. Evidence that serpin architecture intrinsically supports papain-like cysteine protease inhibition: engineering alpha(1)-antitrypsin to inhibit cathepsin proteases.
Irving JA; Pike RN; Dai W; Brömme D; Worrall DM; Silverman GA; Coetzer TH; Dennison C; Bottomley SP; Whisstock JC
Biochemistry; 2002 Apr; 41(15):4998-5004. PubMed ID: 11939796
[TBL] [Abstract][Full Text] [Related]
7. ANISERP: a new serpin from the parasite Anisakis simplex.
Valdivieso E; Perteguer MJ; Hurtado C; Campioli P; Rodríguez E; Saborido A; Martínez-Sernández V; Gómez-Puertas P; Ubeira FM; Gárate T
Parasit Vectors; 2015 Jul; 8():399. PubMed ID: 26215984
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory mechanism of a cross-class serpin, the squamous cell carcinoma antigen 1.
Masumoto K; Sakata Y; Arima K; Nakao I; Izuhara K
J Biol Chem; 2003 Nov; 278(46):45296-304. PubMed ID: 12949073
[TBL] [Abstract][Full Text] [Related]
9. Squamous cell carcinoma antigen 2 is a novel serpin that inhibits the chymotrypsin-like proteinases cathepsin G and mast cell chymase.
Schick C; Kamachi Y; Bartuski AJ; Cataltepe S; Schechter NM; Pemberton PA; Silverman GA
J Biol Chem; 1997 Jan; 272(3):1849-55. PubMed ID: 8999871
[TBL] [Abstract][Full Text] [Related]
10. DNA accelerates the inhibition of human cathepsin V by serpins.
Ong PC; McGowan S; Pearce MC; Irving JA; Kan WT; Grigoryev SA; Turk B; Silverman GA; Brix K; Bottomley SP; Whisstock JC; Pike RN
J Biol Chem; 2007 Dec; 282(51):36980-6. PubMed ID: 17923478
[TBL] [Abstract][Full Text] [Related]
11. The novel bovine serpin endopin 2C demonstrates selective inhibition of the cysteine protease cathepsin L compared to the serine protease elastase, in cross-class inhibition.
Hwang SR; Stoka V; Turk V; Hook VY
Biochemistry; 2005 May; 44(21):7757-67. PubMed ID: 15909990
[TBL] [Abstract][Full Text] [Related]
12. The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites.
Cooley J; Takayama TK; Shapiro SD; Schechter NM; Remold-O'Donnell E
Biochemistry; 2001 Dec; 40(51):15762-70. PubMed ID: 11747453
[TBL] [Abstract][Full Text] [Related]
13. Squamous cell carcinoma antigen is a potent inhibitor of cysteine proteinase cathepsin L.
Takeda A; Yamamoto T; Nakamura Y; Takahashi T; Hibino T
FEBS Lett; 1995 Feb; 359(1):78-80. PubMed ID: 7851535
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of papain by antithrombin due to autolytic digestion: a model of serpin inactivation of cysteine proteinases.
Björk I; Nordling K; Raub-Segall E; Hellman U; Olson ST
Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):701-9. PubMed ID: 9794814
[TBL] [Abstract][Full Text] [Related]
15. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
[TBL] [Abstract][Full Text] [Related]
16. The serpin SQN-5 is a dual mechanistic-class inhibitor of serine and cysteine proteinases.
Al-Khunaizi M; Luke CJ; Askew YS; Pak SC; Askew DJ; Cataltepe S; Miller D; Mills DR; Tsu C; Brömme D; Irving JA; Whisstock JC; Silverman GA
Biochemistry; 2002 Mar; 41(9):3189-99. PubMed ID: 11863458
[TBL] [Abstract][Full Text] [Related]
17. Serpin-glycosaminoglycan interactions.
Rein CM; Desai UR; Church FC
Methods Enzymol; 2011; 501():105-37. PubMed ID: 22078533
[TBL] [Abstract][Full Text] [Related]
18. The Inhibition of Serine Proteases by Serpins Is Augmented by Negatively Charged Heparin: A Concise Review of Some Clinically Relevant Interactions.
Chan ED; King PT; Bai X; Schoffstall AM; Sandhaus RA; Buckle AM
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339082
[TBL] [Abstract][Full Text] [Related]
19. Control of the coagulation system by serpins. Getting by with a little help from glycosaminoglycans.
Pike RN; Buckle AM; le Bonniec BF; Church FC
FEBS J; 2005 Oct; 272(19):4842-51. PubMed ID: 16176258
[TBL] [Abstract][Full Text] [Related]
20. Miropin, a novel bacterial serpin from the periodontopathogen Tannerella forsythia, inhibits a broad range of proteases by using different peptide bonds within the reactive center loop.
Ksiazek M; Mizgalska D; Enghild JJ; Scavenius C; Thogersen IB; Potempa J
J Biol Chem; 2015 Jan; 290(1):658-70. PubMed ID: 25389290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
